Mario Gargiulo's most recent trade in Catalent Inc. was a trade of 678 Common Stock done at an average price of $49.9 . Disclosure was reported to the exchange on May 1, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Catalent Inc. | Mario Gargiulo | SVP, Ops, Biologics Europe | Sale of securities on an exchange or to another person at price $ 49.86 per share. | 01 May 2023 | 678 | 5,676 (0%) | 0% | 49.9 | 33,805 | Common Stock |
| Catalent Inc. | Mario Gargiulo | SVP Global Ops Biologics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2022 | 3,432 | 7,940 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Mario Gargiulo | SVP Global Ops Biologics | Sale of securities on an exchange or to another person at price $ 103.04 per share. | 24 Aug 2022 | 1,586 | 6,354 (0%) | 0% | 103.0 | 163,421 | Common Stock |
| Catalent Inc. | Mario Gargiulo | SVP Global Ops Biologics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2022 | 3,635 | 3,635 | - | - | Options to purchase Common Stock | |
| Catalent Inc. | Mario Gargiulo | SVP Global Ops Biologics | Sale of securities on an exchange or to another person at price $ 106.90 per share. | 26 Jul 2022 | 969 | 3,671 (0%) | 0% | 106.9 | 103,586 | Common Stock |
| Catalent Inc. | Mario Gargiulo | SVP Global Ops Biologics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2022 | 837 | 4,508 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Mario Gargiulo | SVP Global Ops Large Molecule | Sale of securities on an exchange or to another person at price $ 106.59 per share. | 10 Jun 2022 | 118 | 4,640 (0%) | 0% | 106.6 | 12,578 | Common Stock |